Phreesia IPO
Phreesia provides patient intake and engagement platform solutions for healthcare providers, digitizing the patient check-in process and enabling better data collection and workflow optimization. The company's software helps medical practices and health systems improve operational efficiency while enhancing the patient experience.
Key Facts
| Industry | Healthcare Technology |
| Founded | 2005 |
| Headquarters | Wilmington, DE |
| Employees | ~1,800 |
| Website | phreesia.com |
| Funding | Public company (NYSE: PHR) since 2019. IPO raised $110M at $21/share. |
About Phreesia
Phreesia operates a comprehensive healthcare software platform that streamlines patient intake, registration, and engagement processes for medical practices. Their tablet-based solution allows patients to check in, complete forms, update insurance information, and make payments digitally, reducing administrative burden on healthcare staff while improving patient experience. The platform integrates with major electronic health record systems and serves over 2,500 healthcare organizations.
Beyond basic intake functions, Phreesia has expanded into clinical decision support, patient activation tools, and pharmaceutical services that help providers identify eligible patients for specific treatments or clinical trials. Their data insights help healthcare organizations optimize operations and improve patient outcomes. The company went public in 2019 and has grown through strategic acquisitions and organic expansion, positioning itself as a critical infrastructure layer for modern healthcare delivery.
IPO Status
Phreesia went public in July 2019 on the New York Stock Exchange under ticker PHR, raising approximately $110 million. The company priced its IPO at $17 per share and has experienced significant growth as a public company, particularly benefiting from accelerated healthcare digitization during the COVID-19 pandemic. The stock has shown strong performance since going public, though with typical healthcare technology volatility. Phreesia has expanded its platform capabilities and customer base substantially, adding new features around patient engagement, payment processing, and clinical workflows while maintaining strong recurring revenue growth.
Competitors
Frequently Asked Questions
Does Phreesia have a stock?
Yes, Phreesia completed its IPO in July 2019. The patient engagement platform company trades on the NYSE under ticker PHR.
When is the Phreesia IPO date?
Phreesia already completed its IPO on July 18, 2019. The company raised approximately $110 million in the public offering.
How can I buy Phreesia stock?
You can buy Phreesia stock through any brokerage account as it trades on the NYSE under ticker PHR. The stock has been publicly available since 2019.
Don't Miss the Next Big IPO
Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.
Get IPO Alerts